In a prospective study, HE4 demonstrated higher specificity for benign disease compared to CA125, and the combination of HE4 and CA125 showed the highest sensitivity for distinguishing invasive epithelial ovarian cancers from benign ovarian neoplasms [60]. This evidence concerns the gene WFDC2 and ovarian carcinoma.